Face aux nouveaux variants, l’urgence des vaccins: interview sur France24
“Sur les vaccins, plus on ira vite, plus on empêchera de nouveaux variants de surgir”
Rogue antibodies could be driving severe COVID-19
Evidence is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.
Read the full article published by Nature with a contribution from our co-director, Michel Goldman: https://www.nature.com/articles/d41586-021-00149-1 […]
Au bout du jour – Interview for Auvio
During the interview given to RTBF Auvio, our co-director, Michel Goldman stressed the importance of the collective intelligence and collaborative research as keys in the fight against the pandemic. Efficient action beyond the usual divisions […]
L’Echo: La campagne de vaccination est lancée, à quand un relâchement des mesures?
Our co-director, Michel Goldman has given an interview to L’Echo where he discusses COVID-19 vaccines launch in Belgium. Read the full article to find out about the next steps of the vaccination strategy and the […]
Covid-19 et inégalités
Nous avons le plaisir de vous convier au webinaire organisé par le Collège de France et le Collège Belgique, le 15 janvier 2021 de 9h à 12h. Accès libre et gratuit, pas d’inscription préalable
Lien vers […]
Recommendations for a European BARDA
As the EU considers establishing an Agency comparable to the U.S. Biomedical Advanced Research and Development Authority (BARDA), our colleagues outlines a set of recommendations during #A2MDialogues organised by the European Public Health Alliance (EPHA)
Will […]